Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 251 entries
View as:

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01149655 Org: User:
Start: 07/31/11 End: 12/31/13 Due: 12/31/14

A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT02442674 Org: User:
Start: 11/30/15 End: 06/22/17 Due: 06/22/18

Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT05248659 Org: User:
Start: 04/05/22 End: 12/28/28 Due: 12/28/29

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01483183 Org: User:
Start: 11/30/11 End: 10/31/15 Due: 10/31/16

Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01395017 Org: User:
Start: 06/30/11 End: 03/31/15 Due: 03/31/16

Effects of Titrated Oral Tolvaptan 15-60 mg Once Daily (QD) on Cognitive and Neurological Function in Elderly Hyponatremic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00550459 Org: User:
Start: 08/31/07 End: 03/31/09 Due: 03/31/10

A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02969382 Org: User:
Start: 12/05/16 End: 07/31/18 Due: 07/31/19

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00712686 Org: User:
Start: 06/30/00 End: 12/31/03 Due: 12/31/04

Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT01131351 Org: User:
Start: 02/19/10 End: 05/12/11 Due: 05/12/12

A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02435836 Org: User:
Start: 04/30/98 End: 12/31/12 Due: 12/31/13

A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT05428033 Org: User:
Start: 07/11/22 End: 03/17/25 Due: 03/17/26

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01052077 Org: User:
Start: 03/31/10 End: 11/30/11 Due: 11/30/12

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Phase: N/A Priority: Normal
NCT ID: NCT06372210 Org: User:
Start: 06/26/23 End: 07/19/23 Due: 07/19/24

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04398225 Org: User:
Start: 06/11/20 End: 04/01/21 Due: 04/01/22

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00095745 Org: User:
Start: 09/30/04 End: 11/30/07 Due: 11/30/08

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01111552 Org: User:
Start: 07/29/10 End: 09/27/11 Due: 09/27/12

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT00043758 Org: User:
Start: 07/31/02 End: 07/31/04 Due: 07/31/05

An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Participants With Euvolemic or Hypervolemic Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT02020278 Org: User:
Start: 04/22/16 End: 10/23/17 Due: 10/23/18

Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase: N/A Priority: Normal
NCT ID: NCT01336972 Org: User:
Start: 10/31/10 End: 11/30/11 Due: 11/30/12

Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT01227512 Org: User:
Start: 10/31/10 End: 05/31/13 Due: 05/31/14

Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02251275 Org: User:
Start: 10/17/14 End: 11/09/18 Due: 11/09/19

A Switch Study of BMS-337039 in Schizophrenic Out-patients

Phase: N/A Priority: Normal
NCT ID: NCT00232687 Org: User:
Start: 06/30/05 End: 04/30/07 Due: 04/30/08

A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01940159 Org: User:
Start: 08/31/13 End: 03/31/14 Due: 03/31/15

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Phase: N/A Priority: Normal
NCT ID: NCT01567527 Org: User:
Start: 08/31/12 End: 04/30/16 Due: 04/30/17

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Phase: N/A Priority: Normal
NCT ID: NCT02722967 Org: User:
Start: 03/31/16 End: 09/30/16 Due: 09/30/17